{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:01:54Z","timestamp":1785726114516,"version":"3.56.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["UNCE\/MED\/007"],"award-info":[{"award-number":["UNCE\/MED\/007"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015982","name":"Midwest Athletes Against Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU21-08-00324"],"award-info":[{"award-number":["NU21-08-00324"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["LX22NPO5104"],"award-info":[{"award-number":["LX22NPO5104"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008980","name":"Medical College of Wisconsin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ymthe.2024.08.004","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:03:39Z","timestamp":1722888219000},"page":"3402-3421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hematopoietic stem cell transplantation leads to biochemical and functional correction in two mouse models of acid ceramidase deficiency"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4779-638X","authenticated-orcid":false,"given":"Jitka","family":"Rybova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Sundararajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Kuchar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A.","family":"Dlugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Ruzicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"McKillop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8165-8995","authenticated-orcid":false,"given":"Jeffrey A.","family":"Medin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.08.004_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13023-018-0845-z","article-title":"Acid ceramidase deficiency: Farber disease and SMA-PME","volume":"13","author":"Yu","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2024.08.004_bib2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0022-3476(84)81106-3","article-title":"Phenotypic variability in siblings with Farber disease","volume":"104","author":"Antonarakis","year":"1984","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.ymthe.2024.08.004_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1546-0096-5-15","article-title":"Farber disease: clinical presentation, pathogenesis and a new approach to treatment","volume":"5","author":"Ehlert","year":"2007","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.ymthe.2024.08.004_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13052-023-01474-z","article-title":"Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME): three new cases and review of the mutational spectrum","volume":"49","author":"Najafi","year":"2023","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.ymthe.2024.08.004_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/biom13020274","article-title":"Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions","volume":"13","author":"Kleynerman","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2024.08.004_bib6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/cge.12307","article-title":"Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy","volume":"86","author":"Dyment","year":"2014","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymthe.2024.08.004_bib7","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/acn3.51687","article-title":"The clinical spectrum of SMA-PME and in\u00a0vitro normalization of its cellular ceramide profile","volume":"9","author":"Lee","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymthe.2024.08.004_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-981-19-0394-6_13","article-title":"Rare Diseases in Glycosphingolipid Metabolism","volume":"1372","author":"Zhou","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymthe.2024.08.004_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.885639","article-title":"New Indications for Hematopoietic Stem Cell Gene Therapy in Lysosomal Storage Disorders","volume":"12","author":"Rossini","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2024.08.004_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy","volume":"257","author":"Thomas","year":"1957","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.08.004_bib11","first-page":"91","article-title":"Hematopoietic Stem Cell Transplant for Lysosomal Storage Diseases","volume":"11","author":"Lund","year":"2013","journal-title":"Pediatr. Endocr. Rev. P"},{"key":"10.1016\/j.ymthe.2024.08.004_bib12","first-page":"207","article-title":"Novel Approaches and Mechanisms in Hematopoietic Stem Cell Gene Therapy","volume":"17","author":"Bigger","year":"2014","journal-title":"Discov. Med."},{"key":"10.1016\/j.ymthe.2024.08.004_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fped.2019.00433","article-title":"Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism","volume":"7","author":"Tan","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymthe.2024.08.004_bib14","first-page":"S145","article-title":"Hematopoietic stem cell transplantation for mucopolysaccharidoses past, present, and future","volume":"126","author":"Tomatsu","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2024.08.004_bib15","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/ard.2005.048322","article-title":"Farber's disease without central nervous system involvement: bone-marrow transplantation provides a promising new approach","volume":"65","author":"Ehlert","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ymthe.2024.08.004_bib16","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1007\/s10545-009-9035-4","article-title":"The effects of early and late bone marrow transplantation in siblings with alpha-mannosidosis. Is early haematopoietic cell transplantation the preferred treatment option?","volume":"33","author":"Broomfield","year":"2010","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2024.08.004_bib17","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.08.004_bib18","first-page":"46","article-title":"Hematopoietic stem cell transplant does not prevent neurological deterioration in infants with Farber disease: Case report and literature review","volume":"46","author":"Goudie","year":"2019","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymthe.2024.08.004_bib19","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ajpath.2016.12.005","article-title":"Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities","volume":"187","author":"Sikora","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2024.08.004_bib20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ajpath.2018.10.018","article-title":"Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment","volume":"189","author":"Yu","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2024.08.004_bib21","doi-asserted-by":"crossref","first-page":"L406","DOI":"10.1152\/ajplung.00223.2017","article-title":"Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency","volume":"314","author":"Yu","year":"2018","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ymthe.2024.08.004_bib22","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.3324\/haematol.2014.108530","article-title":"Markedly perturbed hematopoiesis in acid ceramidase deficient mice","volume":"100","author":"Dworski","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.ymthe.2024.08.004_bib23","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/jimd.12552","article-title":"Skin inflammation and impaired adipogenesis in a mouse model of acid ceramidase deficiency","volume":"45","author":"Rybova","year":"2022","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2024.08.004_bib24","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/s41374-019-0271-4","article-title":"Hepatic pathology and altered gene transcription in a murine model of acid ceramidase deficiency","volume":"99","author":"Yu","year":"2019","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ymthe.2024.08.004_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/emmm.201202301","article-title":"Systemic ceramide accumulation leads to severe and varied pathological consequences","volume":"5","author":"Alayoubi","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2024.08.004_bib26","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s42003-023-04932-w","article-title":"Spinal muscular atrophy-like phenotype in a mouse model of acid ceramidase deficiency","volume":"6","author":"Nagree","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ymthe.2024.08.004_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbadis.2016.11.031","article-title":"Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy","volume":"1863","author":"Dworski","year":"2017","journal-title":"BBA - Mol. Basis Dis."},{"key":"10.1016\/j.ymthe.2024.08.004_bib28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1515\/hsz-2018-0170","article-title":"Pathological manifestations of Farber disease in a new mouse model","volume":"399","author":"Beckmann","year":"2018","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.08.004_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10545-015-9890-0","article-title":"Nervous system involvement in Farber disease","volume":"39","author":"Cappellari","year":"2016","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2024.08.004_bib30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/gim.2017.133","article-title":"A cross-sectional quantitative analysis of the natural history of Farber disease: an ultra-orphan condition with rheumatologic and neurological cardinal disease features","volume":"20","author":"Zielonka","year":"2018","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2024.08.004_bib31","doi-asserted-by":"crossref","first-page":"434.e1","DOI":"10.1016\/j.jtct.2021.02.013","article-title":"Late Kidney Morbidity and Mortality in Hematopoietic Cell Transplant Survivors","volume":"27","author":"Wu","year":"2021","journal-title":"Transpl. Cell. Ther."},{"key":"10.1016\/j.ymthe.2024.08.004_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.bmt.1705573","article-title":"Chronic kidney disease in long-term survivors of hematopoietic cell transplant","volume":"39","author":"Hingorani","year":"2007","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.ymthe.2024.08.004_bib33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jpeds.2008.11.005","article-title":"Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy","volume":"154","author":"Wynn","year":"2009","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.ymthe.2024.08.004_bib34","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/rheumatology\/keu010","article-title":"Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation","volume":"53","author":"Torcoletti","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ymthe.2024.08.004_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF01600282","article-title":"Farber disease: an ultrastructural study. Report of a case and review of the literature","volume":"420","author":"Zappatini-Tommasi","year":"1992","journal-title":"Virchows Arch. A. Pathol. Anat. Histopathol."},{"key":"10.1016\/j.ymthe.2024.08.004_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107598","article-title":"MCP-1: Function, regulation, and involvement in disease","volume":"101","author":"Singh","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymthe.2024.08.004_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.addr.2017.05.004","article-title":"Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives","volume":"118","author":"Solomon","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2024.08.004_bib38","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM196903272801303","article-title":"Intrauterine diagnosis of the hurler and hunter syndromes","volume":"280","author":"Fratantoni","year":"1969","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.08.004_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.559804","article-title":"CNS-Targeting Therapies for Lysosomal Storage Diseases: Current Advances and Challenges","volume":"7","author":"Edelmann","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymthe.2024.08.004_bib40","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.ymgme.2016.11.310","article-title":"Proof-of-concept studies underlying enzyme replacement therapy for acid ceramidase deficiency","volume":"120","author":"Schuchman","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2024.08.004_bib41","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.ymgme.2015.12.364","article-title":"Farber disease: Implications of anti-inflammatory treatment","volume":"117","author":"Mitchell","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2024.08.004_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jpeds.2003.09.051","article-title":"Successful hematopoietic stem cell transplantation in Farber disease","volume":"144","author":"Vormoor","year":"2004","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.ymthe.2024.08.004_bib43","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/acn3.51687","article-title":"The clinical spectrum of SMA-PME and in\u00a0vitro normalization of its cellular ceramide profile","volume":"9","author":"Lee","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymthe.2024.08.004_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10072-021-05291-2","article-title":"An open-label phase 1 clinical trial of the allogeneic side population adipose-derived mesenchymal stem cells in SMA type 1 patients","volume":"43","author":"Mohseni","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ymthe.2024.08.004_bib45","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.nbd.2007.01.008","article-title":"Neuroprotective effect of adult hematopoietic stem cells in a mouse model of motoneuron degeneration","volume":"26","author":"Cabanes","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2024.08.004_bib46","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ajpath.2020.02.008","article-title":"Podocytopathy and Nephrotic Syndrome in Mice with Podocyte-Specific Deletion of the Asah1 Gene: Role of Ceramide Accumulation in Glomeruli","volume":"190","author":"Li","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2024.08.004_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2215\/CJN.08580719","article-title":"Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation","volume":"15","author":"Renaghan","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2024.08.004_bib48","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.3390\/cancers15143720","article-title":"Predictive Risk Score for Acute Kidney Injury in Hematopoietic Stem Cell Transplant","volume":"15","author":"Rodrigues","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2024.08.004_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12885-021-07897-3","article-title":"Early transplantation-related mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia","volume":"21","author":"Kong","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ymthe.2024.08.004_bib50","doi-asserted-by":"crossref","first-page":"9645","DOI":"10.3390\/ijms21249645","article-title":"Gangliosides in Podocyte Biology and Disease","volume":"21","author":"Savas","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.08.004_bib51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/BJ20041506","article-title":"Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides","volume":"388","author":"Masson","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2024.08.004_bib52","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1631","article-title":"Immune Cell Isolation from Mouse Femur Bone Marrow","volume":"5","author":"Liu","year":"2015","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.ymthe.2024.08.004_bib53","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis.","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.ymthe.2024.08.004_bib54","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0003-2697(72)90094-2","article-title":"Determination of protein: a modification of the Lowry method that gives a linear photometric response","volume":"48","author":"Hartree","year":"1972","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymthe.2024.08.004_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100121","article-title":"Crosstalk between ORMDL3, serine palmitoyltransferase, and 5-lipoxygenase in the sphingolipid and eicosanoid metabolic pathways","volume":"62","author":"Bugajev","year":"2021","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.ymthe.2024.08.004_bib56","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ajmg.a.32712","article-title":"Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations","volume":"149A","author":"Kuchar","year":"2009","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.ymthe.2024.08.004_bib57","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/glycob\/cws050","article-title":"Glycosphingolipid profile of the apical pole of human placental capillaries: the relevancy of the observed data to Fabry disease","volume":"22","author":"Hulkova","year":"2012","journal-title":"Glycobiology"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624005264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624005264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T12:48:40Z","timestamp":1758199720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624005264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1525001624005264"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.08.004","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic stem cell transplantation leads to biochemical and functional correction in two mouse models of acid ceramidase deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}